We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-5.11%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.4B
AUM Growth
-$929M
Cap. Flow
-$275M
Cap. Flow %
-2.65%
Top 10 Hldgs %
43.03%
Holding
1,068
New
166
Increased
266
Reduced
450
Closed
162

Sector Composition

Rank Sector Weight
1 Energy 50.72%
2 Financials 11.42%
3 Technology 6.62%
4 Healthcare 4.85%
5 Consumer Discretionary 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIP icon
301
Brookfield Infrastructure Partners
BIP
$18.8B
$2.19M 0.02%
58,575
-1,350
-2% -$50.1K
RGNX icon
302
Regenxbio
RGNX
$623M
$2.19M 0.02%
52,212
-3,772
-7% -$136K
RMD icon
303
ResMed
RMD
$28.3B
$2.19M 0.02%
8,306
-3,618
-30% -$989K
OKTA icon
304
Okta
OKTA
$24.1B
$2.19M 0.02%
9,212
-878
-9% -$218K
ABMD
305
DELISTED
Abiomed Inc
ABMD
$2.19M 0.02%
6,712
-1,903
-22% -$645K
ZM icon
306
Zoom
ZM
$25.8B
$2.17M 0.02%
8,294
+821
+11% +$277K
TXN icon
307
Texas Instruments
TXN
$255B
$2.14M 0.02%
11,145
+197
+2% +$37.5K
ARES icon
308
Ares Management
ARES
$28.5B
$2.14M 0.02%
29,000
-1,200
-4% -$86.4K
SYK icon
309
Stryker
SYK
$127B
$2.13M 0.02%
8,070
+840
+12% +$225K
FSK icon
310
FS KKR Capital
FSK
$2.98B
$2.12M 0.02%
96,200
+24,301
+34% +$536K
BEEM icon
311
Beam Global
BEEM
$22.4M
$2.08M 0.02%
75,856
+9,666
+15% +$287K
NSLR
312
Neostellar Capital Corp
NSLR
$262M
$2.07M 0.02%
160,500
-5,444
-3% -$71.5K
ISEE
313
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.07M 0.02%
127,476
+8,598
+7% +$93.6K
CL icon
314
Colgate-Palmolive
CL
$72.6B
$2.06M 0.02%
27,223
-5,591
-17% -$444K
ROL icon
315
Rollins
ROL
$18.6B
$2.04M 0.02%
57,623
-1,835
-3% -$68.7K
MTLS
316
Materialise
MTLS
$379M
$2.02M 0.02%
100,680
+2,762
+3% +$60.5K
SA
317
Seabridge Gold
SA
$2.8B
$2.01M 0.02%
129,954
+7,402
+6% +$128K
NOC icon
318
Northrop Grumman
NOC
$77B
$2M 0.02%
5,563
-297
-5% -$107K
KLRS
319
Kalaris Therapeutics
KLRS
$88.7M
$2M 0.02%
3,470
-258
-7% -$119K
IMCR icon
320
Immunocore
IMCR
$1.78B
$1.99M 0.02%
53,663
-3,610
-6% -$122K
GBT
321
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.95M 0.02%
76,497
-5,014
-6% -$147K
MOR
322
DELISTED
MorphoSys AG American Depositary Shares
MOR
$1.95M 0.02%
165,509
-7,085
-4% -$103K
PAYX icon
323
Paychex
PAYX
$40.4B
$1.94M 0.02%
17,268
-146
-0.8% -$16.4K
STNE icon
324
StoneCo
STNE
$2.62B
$1.94M 0.02%
55,946
+20,398
+57% +$1.06M
DRNA
325
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.92M 0.02%
95,276
+86,586
+996% +$2.39M

Similar funds

ALPS Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, ALPS Advisors held 1,068 positions worth $10.4B, down 8.2% from $11.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

ALPS Advisors's Q3 2021 filing shows 166 new, 266 increased, 450 reduced and 162 closed positions. Its largest new stake was Stem: 59,506 shares worth $28.4M. The largest sale was MPLX, an estimated $69.6M.

By sector, the portfolio is most concentrated in Energy at 51% of assets, down from 53% a quarter earlier, followed by Financials and Technology.

  • ALPS Advisors's largest Q3 2021 buy was Stem: 59,506 shares worth $28.4M.
  • ALPS Advisors added most to ENLINK MIDSTREAM, LLC in Q3 2021, an estimated $39.9M increase.
  • ALPS Advisors's biggest Q3 2021 reduction was MPLX, cutting an estimated $69.6M.
  • ALPS Advisors fully exited Universal Display in Q3 2021, selling an estimated $47.2M.
  • ALPS Advisors's ten largest holdings make up 43% of its $10.4B portfolio in Q3 2021.
  • ALPS Advisors opened 166 new positions and closed 162 in Q3 2021.
  • ALPS Advisors's portfolio value fell 8.2% quarter-over-quarter to $10.4B.

Based on ALPS Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.